Table 1 Simulated population size (total population)
From: Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
Age group | General population | High risk* | Moderate risk* |
|---|---|---|---|
< 5 | 2,730,000 | 4,600 | 16,000 |
5 - 17 | 10,070,000 | 75,100 | 260,000 |
18 - 39 | 21,700,000 | 405,000 | 1,400,000 |
40 - 59 | 25,500,000 | 1,001,000 | 2,777,000 |
60+ | 22,000,000 | 2,874,000 | 7,415,000 |
Total | 82,000,000 | 4,359,700 | 11,868,000 |